In addition, pharmacological activation of NR4A2 reduced Aβ plaque deposition in the subiculum and significantly ameliorated AD-like pathology in 5X-FAD mice, including neuronal loss, microglial activation and impaired neurogenesis in the adult hippocampus [134]. The gene discussed is NR4A2; the disease is Alzheimer disease.